The following information is based on a press release from Active Biotech AB (Active Biotech) published on November 5, 2014 and may be subject to change.
The board of Active Biotech has proposed that the Extraordinary General Meeting (EGM), scheduled for December 1, 2014 approves a rights issue whereby shareholders are entitled to one (1) new share for every five (5) shares held. The subscription price is SEK 15.00 per share. The scheduled Ex-date is December 3, 2014. Provided that the EGM approves the rights issue, NASDAQ OMX Derivatives Markets will carry out a re-calculation of options, forwards and futures in Active Biotech (ACTIB).
For further information, please see the attached file.
